A Phase 2 interventional study of BCG vaccine in MAC lung disease
Recruiting Phase 2 NCT07094711
Study Description
A study to test whether the BCG vaccine can safely and effectively treat Mycobacterium avium complex (MAC) lung infections
Study Details
- Registry ID:
- NCT07094711
- Conditions:
- Mycobacterium Avium-intracellulare Infection, Mycobacterium Infections, Nontuberculous
- Phase:
- Phase 2
- Target Enrollment:
- 48 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
University of Virginia Health
Charlottesville, Virginia, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.